KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,000 | -92.9% | 3 | -98.3% | 0.00% | -100.0% |
| Q1 2017 | $14,000 | -81.6% | 175 | -89.7% | 0.00% | -75.0% |
| Q4 2016 | $76,000 | +81.0% | 1,700 | +126.7% | 0.00% | +100.0% |
| Q3 2016 | $42,000 | +23.5% | 750 | +10.3% | 0.00% | 0.0% |
| Q2 2016 | $34,000 | +277.8% | 680 | +353.3% | 0.00% | +100.0% |
| Q4 2015 | $9,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $185,086,000 | 58.62% |
| BAINCO INTERNATIONAL INVESTORS | 879,840 | $69,059,000 | 9.77% |
| Coastal Bridge Advisors, LLC | 235,140 | $18,456,000 | 6.29% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,433,899 | $112,547,000 | 5.71% |
| NEXTHERA CAPITAL LP | 105,000 | $8,241,000 | 4.20% |
| ARK Investment Management | 87,364 | $6,857,000 | 1.98% |
| Casdin Capital, LLC | 42,500 | $3,336,000 | 1.97% |
| BB BIOTECH AG | 740,000 | $58,083,000 | 1.90% |
| FT Options LLC | 81,700 | $1,287,000 | 1.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 55,500 | $4,346,000 | 1.66% |